Equitable Access to COVID-19 Vaccines
Enabling Equitable Access to COVID-19 Vaccine in Under-Resourced Communities
1 other identifier
interventional
1,722
1 country
1
Brief Summary
This study will deploy a multimodal pragmatic intervention to improve vaccine uptake in priority populations and address vaccine hesitancy to improve access by using a proactive organized population-based outreach leveraging health information technology with tailored navigation support to address mistrust and social barriers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable covid19
Started Apr 2021
Shorter than P25 for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2021
CompletedFirst Posted
Study publicly available on registry
July 7, 2021
CompletedMarch 18, 2022
March 1, 2022
2 months
June 7, 2021
March 17, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Dose 1 COVID-19 Vaccine
Primary outcome will be the receipt of the first dose of any of the COVID-19 vaccines with FDA emergency use authorization
30 days
Secondary Outcomes (1)
Dose 2 COVID-19 Vaccine
60 days
Other Outcomes (1)
Engagement
30 days
Study Arms (3)
Short message service (SMS)
ACTIVE COMPARATORSubjects will receive vaccine availability and appointment information via SMS.
Personalized text message
EXPERIMENTALSubjects will receive vaccine availability and appointment information via a personalized message text from the primary care provider (PCP).
Interactive or 2-way SMS
EXPERIMENTALSubjects will receive vaccine availability and appointment information via interactive 2-way SMS options.
Interventions
Patients are informed via SMS that COVID-19 vaccine doses are available and advised to schedule an appointment. Links to information or phone for scheduling will be provided. Messages mimic the clinic's usual practice of information delivery to patients
Patients are informed via SMS that COVID-19 vaccine doses are available and advised to schedule an appointment. The SMS message is personalized as a recommendation from the primary care clinician
This intervention is same as in the Arm 2 using personalized messaging from the PCP. In addition, patients are given interactive or 2-way SMS options to obtain additional information about COVID vaccine and answers to frequently asked questions.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- Adelante Healthcarecollaborator
Study Sites (1)
Mayo Clinic
Scottsdale, Arizona, 85259, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chyke Doubeni, MD, MPH
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 7, 2021
First Posted
July 7, 2021
Study Start
April 1, 2021
Primary Completion
June 10, 2021
Study Completion
June 10, 2021
Last Updated
March 18, 2022
Record last verified: 2022-03